TY - JOUR T1 - Alzheimer dementia: Starting, stopping drug therapy JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 209 LP - 214 DO - 10.3949/ccjm.85a.16080 VL - 85 IS - 3 AU - Luke D. Kim AU - Ronan M. Factora Y1 - 2018/03/01 UR - http://www.ccjm.org/content/85/3/209.abstract N2 - Alzheimer disease is the most common type of dementia. Two classes of cognition-enhancing drugs are approved to treat the symptoms, and both have provided modest benefit in clinical trials. Psychotropic drugs are sometimes used off-label to treat behavioral symptoms of Alzheimer disease. All these medications should be continuously evaluated for clinical efficacy and, when appropriate, discontinued if the primary benefit—preservation of cognitive and functional status and a reduction in behaviors associated with dementia—is no longer being achieved. ER -